Cresco Labs Inc.
CRLBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $724 | $771 | $843 | $822 |
| % Growth | -6% | -8.5% | 2.6% | – |
| Cost of Goods Sold | $360 | $409 | $436 | $415 |
| Gross Profit | $364 | $330 | $407 | $406 |
| % Margin | 50.3% | 42.8% | 48.3% | 49.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $232 | $275 | $55 | $40 |
| SG&A Expenses | $232 | $275 | $351 | $318 |
| Sales & Mktg Exp. | $0 | $0 | $16 | $30 |
| Other Operating Expenses | $25 | $178 | $141 | $306 |
| Operating Expenses | $257 | $435 | $350 | $319 |
| Operating Income | $107 | -$88 | -$84 | -$217 |
| % Margin | 14.8% | -11.4% | -10% | -26.5% |
| Other Income/Exp. Net | -$118 | -$59 | -$43 | -$39 |
| Pre-Tax Income | -$11 | -$147 | -$127 | -$257 |
| Tax Expense | $50 | $33 | $89 | $40 |
| Net Income | -$74 | -$176 | -$212 | -$320 |
| % Margin | -10.3% | -22.8% | -25.2% | -38.9% |
| EPS | -0.22 | -0.54 | -0.71 | -1.22 |
| % Growth | 59.3% | 23.9% | 41.8% | – |
| EPS Diluted | -0.22 | -0.54 | -0.71 | -1.22 |
| Weighted Avg Shares Out | 345 | 324 | 298 | 262 |
| Weighted Avg Shares Out Dil | 345 | 324 | 298 | 262 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $2 | $1 | $1 |
| Interest Expense | $59 | $64 | $59 | $52 |
| Depreciation & Amortization | $63 | $69 | $55 | $45 |
| EBITDA | $109 | -$15 | -$10 | -$157 |
| % Margin | 15% | -1.9% | -1.2% | -19.1% |